Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial
<p>Abstract</p> <p>Background</p> <p>Young women in sub-Saharan Africa bear a disproportionate burden of HIV infection compared to men but have limited options to reduce their HIV risk. Microbicides could fill an important HIV prevention gap for sexually active women wh...
Main Authors: | Gengiah Tanuja N, Omar Zaheen, Sibeko Sengeziwe, Grobler Anneke, Arulappan Natasha, Maarschalk Silvia, Mlisana Koleka P, Mansoor Leila E, Yende Nonhlanhla, Baxter Cheryl, Frohlich Janet A, Kharsany Ayesha BM, Karim Quarraisha, Mlotshwa Mukelisiwe, Samsunder Natasha, Abdool Karim Salim S |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-03-01
|
Series: | Trials |
Online Access: | http://www.trialsjournal.com/content/12/1/67 |
Similar Items
-
Women with pregnancies had lower adherence to 1% tenofovir vaginal gel as HIV preexposure prophylaxis in CAPRISA 004, a phase IIB randomized-controlled trial.
by: Lynn T Matthews, et al.
Published: (2013-01-01) -
HIV prevalence among high school learners - opportunities for schools-based HIV testing programmes and sexual reproductive health services
by: Kharsany Ayesha BM, et al.
Published: (2012-03-01) -
Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)
by: Burgers WA, et al.
Published: (2012-09-01) -
Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women.
by: Vineet Joag, et al.
Published: (2018-01-01) -
Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study.
by: Francois van Loggerenberg, et al.
Published: (2008-04-01)